Updated on 2026/01/28

写真a

 
yasuko fukataki
 
Organization
School of Medicine Department of Medical Statistics Assistant Professor
Title
Assistant Professor
External link

Degree

  • 人間学(修士)

Research Interests

  • Clinical Research Informatics

  • Digital Health

  • Retrieval-Augmented Generation (RAG)

  • Knowledge Quality

  • Artificial Intelligence in Healthcare

  • IRB Support Systems

  • HCI

  • Human-AI Interaction(HAI)

Research Areas

  • Life Science / Medical systems

Education

  • 武蔵野大学大学院 通信教育部   人間学研究科 人間学専攻

    2020.4 - 2022.3

      More details

    Country: Japan

    Notes: 修士(人間学)

    researchmap

  • 北海道大学 大学院医学院   社会医学講座 ヘルスデータサイエンス教室

    2024.4

      More details

    Country: Japan

    Notes: 臨床研究関連文書に対する生成AI・RAGの品質評価および倫理支援システムの構築

    researchmap

Professional Memberships

  • The Hokkaido Medical Society

    2025.8

      More details

  • Japanese Association for Medical Artificial Intelligence

    2025.5

      More details

  • 日本臨床試験学会

    2022.11

      More details

Papers

  • Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study. International journal

    Yutaro Nagano, Mamoru Takahashi, Toshiyuki Sumi, Keiki Yokoo, Tatsuru Ishikawa, Osamu Honjo, Sayaka Kudo, Shun Kondo, Yusuke Tanaka, Makoto Shioya, Midori Hashimoto, Mitsuo Otsuka, Yuta Sudo, Masahiro Yanagi, Hayato Yabe, Hirotaka Nishikiori, Masami Yamazoe, Yuichiro Asai, Yasuko Fukataki, Shiro Hinotsu, Hirofumi Chiba

    Japanese journal of clinical oncology   55 ( 8 )   933 - 940   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Programmed death ligand 1 (PD-L1) serves as a crucial biomarker for predicting the efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer (NSCLC). This study aimed to identify the most suitable first-line treatment regimen for patients with PD-L1 expression <1% (PD-L1-negative) NSCLC by comparing nivolumab plus ipilimumab (NI), NI combined with chemotherapy (NICT), and pembrolizumab and chemotherapy (PCT). METHODS: We analyzed data from 141 patients with PD-L1-negative NSCLC treated with NI, NICT, or PCT at 14 Japanese institutions between December 2020 and November 2022. Propensity score analysis was employed to minimize selection bias, and Kaplan-Meier analysis and Cox proportional hazards regression were used to evaluate progression-free survival (PFS) and overall survival (OS). RESULTS: Neither NI nor NICT demonstrated superior PFS or OS than PCT. Subgroup analyses revealed no significant differences between treatment groups across age, histological subtypes, or clinical features. Results from propensity score matching and inverse probability of treatment weighting were consistent with those observed in the overall cohort. Moreover, safety profiles showed that PCT was associated with the lowest rates of treatment discontinuation and immune-related adverse events requiring systemic corticosteroid therapy. CONCLUSIONS: In patients with PD-L1-negative NSCLC, the efficacy of NI and NICT was not superior to that of PCT. Thus, we concluded that PCT could be a favorable treatment option for this patient population.

    DOI: 10.1093/jjco/hyaf073

    PubMed

    researchmap

  • Developing artificial intelligence tools for institutional review board pre-review: A pilot study on ChatGPT's accuracy and reproducibility. International journal

    Yasuko Fukataki, Wakako Hayashi, Naoki Nishimoto, Yoichi M Ito

    PLOS digital health   4 ( 6 )   e0000695   2025.6

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    This pilot study is the first phase of a broader project aimed at developing an explainable artificial intelligence (AI) tool to support the ethical evaluation of Japanese-language clinical research documents. The tool is explicitly not intended to assist document drafting. We assessed the baseline performance of generative AI-Generative Pre-trained Transformer (GPT)-4 and GPT-4o-in analyzing clinical research protocols and informed consent forms (ICFs). The goal was to determine whether these models could accurately and consistently extract ethically relevant information, including the research objectives and background, research design, and participant-related risks and benefits. First, we compared the performance of GPT-4 and GPT-4o using custom agents developed via OpenAI's Custom GPT functionality (hereafter "GPTs"). Then, using GPT-4o alone, we compared outputs generated by GPTs optimized with customized Japanese prompts to those generated by standard prompts. GPT-4o achieved 80% agreement in extracting research objectives and background and 100% in extracting research design, while both models demonstrated high reproducibility across ten trials. GPTs with customized prompts produced more accurate and consistent outputs than standard prompts. This study suggests the potential utility of generative AI in pre-institutional review board (IRB) review tasks; it also provides foundational data for future validation and standardization efforts involving retrieval-augmented generation and fine-tuning. Importantly, this tool is intended not to automate ethical review but rather to support IRB decision-making. Limitations include the absence of gold standard reference data, reliance on a single evaluator, lack of convergence and inter-rater reliability analysis, and the inability of AI to substitute for in-person elements such as site visits.

    DOI: 10.1371/journal.pdig.0000695

    PubMed

    researchmap

  • A Safer Method for Disinfection of Bacillus Calmette-Guerin-Containing Urine: A Prospective, Randomized Study. International journal

    Tomohiro Kameda, Yoshimasa Kondo, Yasuko Fukataki, Shiro Hinotsu, Tetsuya Fujimura, Tatsuya Takayama

    Urologia internationalis   108 ( 5 )   377 - 382   2024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: The aim of the study was to examine whether disinfection of bacillus Calmette-Guerin-containing urine with etaprocohol® (ethanol 76.9-81.4 vol % and isopropanol as an additive) is safer than disinfection with sodium hypochlorite. METHOD: In prospective research, safety and efficacy was analyzed in 5 patients in the etaprocohol® disinfection group and 5 patients in the sodium hypochlorite disinfection group. The primary endpoint was the temperature change after disinfection and the secondary endpoint was the unpleasantness of the odor caused by disinfection. Additionally, concentration of gas produced was also examined. Sensory tests were taken from staff who performed urine disinfection and the odor generated by disinfection was evaluated. As a safety protocol, post-BCG-treated urine is cultured to verify the negativity for mycobacteria. RESULTS: Mycobacteria were disinfected in all cases. The temperature rise following disinfection was significantly higher in the sodium hypochlorite group. The sensory test outcomes were significantly worse in the group disinfected with sodium hypochlorite. The concentration of gas generated immediately after disinfection in both groups reached the maximum value and declined quickly. CONCLUSIONS: Disinfection of bacillus Calmette-Guerin-containing urine with etaprocohol® was safer than disinfection with sodium hypochlorite, and an equivalent disinfection effect was achieved.

    DOI: 10.1159/000538758

    PubMed

    researchmap

  • Evaluation of a Medical Interview-Assistance System Using Artificial Intelligence for Resident Physicians Interviewing Simulated Patients: A Crossover, Randomized, Controlled Trial. International journal

    Akio Kanazawa, Kazutoshi Fujibayashi, Yu Watanabe, Seiko Kushiro, Naotake Yanagisawa, Yasuko Fukataki, Sakiko Kitamura, Wakako Hayashi, Masashi Nagao, Yuji Nishizaki, Takenori Inomata, Eri Arikawa-Hirasawa, Toshio Naito

    International journal of environmental research and public health   20 ( 12 )   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Medical interviews are expected to undergo a major transformation through the use of artificial intelligence. However, artificial intelligence-based systems that support medical interviews are not yet widespread in Japan, and their usefulness is unclear. A randomized, controlled trial to determine the usefulness of a commercial medical interview support system using a question flow chart-type application based on a Bayesian model was conducted. Ten resident physicians were allocated to two groups with or without information from an artificial intelligence-based support system. The rate of correct diagnoses, amount of time to complete the interviews, and number of questions they asked were compared between the two groups. Two trials were conducted on different dates, with a total of 20 resident physicians participating. Data for 192 differential diagnoses were obtained. There was a significant difference in the rate of correct diagnosis between the two groups for two cases and for overall cases (0.561 vs. 0.393; p = 0.02). There was a significant difference in the time required between the two groups for overall cases (370 s (352-387) vs. 390 s (373-406), p = 0.04). Artificial intelligence-assisted medical interviews helped resident physicians make more accurate diagnoses and reduced consultation time. The widespread use of artificial intelligence systems in clinical settings could contribute to improving the quality of medical care.

    DOI: 10.3390/ijerph20126176

    PubMed

    researchmap

  • 新型コロナウイルス感染症が学校・教育現場にもたらした影響 ─ 日本および世界各国の大学における オンライン授業導入の影響と今後の可能性─

    深瀧 恭子

    人間学研究論集   ( 12 )   2023.3

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

Presentations

  • Is Generative AI a Tool or a Partner? — Insights from Practical Experience

    Yasuko Fukataki

    The 9th Kagoshima Data Science Symposium in Fukuoka  2025.12 

     More details

    Event date: 2025.12

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    researchmap

  • 臨床試験支援業務の効率化を目指したRobotic Process Automation教育の実践 ― 初心者による初心者の視点からのわかりやすさと学びやすさの探求

    深瀧 恭子

    第15回 日本臨床試験学会学術集会総会  2024.3 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 高度なIT関連およびプログラミングの知識を有さずともDXを推進するためのPower

    深瀧 恭子

    第14回 日本臨床試験学会学術集会総会  2023.2 

     More details

    Presentation type:Poster presentation  

    researchmap

  • アカデミアの臨床研究支援業務におけるDX導入のための試み

    深瀧 恭子

    第14回 日本臨床試験学会学術集会総会  2023.2 

     More details

    Presentation type:Poster presentation  

    researchmap

  • 生成AIを用いた臨床研究の倫理審査:ChatGPTの正確性と再現性の評価

    深瀧 恭子

    第16回 日本臨床試験学会学術集会総会  2025.2 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

Awards

  • Best Oral Presentation Award, Hokkaido University CLAP Achievement Presentation 2024

    2025.3   Hokkaido University   Development of an AI System for IRB Pre-review: A Pilot Study Evaluating the Accuracy and Reproducibility of ChatGPT

    Yasuko Fukataki

     More details

Research Projects

  • 医学論文検索における生成AI技術導入の有用性および妥当性の検証

    Grant number:24K15655  2024.4 - 2027.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    樋之津 史郎, 深瀧 恭子

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap